Expression systems and developments in plant-made vaccines

Immunology and Cell Biology

Volumn 83, Issue 3, 2005, Pages 271-277

  Rigano, M Manuela ^a   Walmsley, Amanda M ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Expression system; Oral immunization; Plant made vaccine; Targeting protein; Transgenic plant

Indexed keywords

ADJUVANT; ANTIGEN; PLANT MADE VACCINE; PROTEIN; UNCLASSIFIED DRUG; VACCINE;

CELLULAR IMMUNITY; CHLOROPLAST; DRUG DELIVERY SYSTEM; DRUG SAFETY; FOOD PROCESSING; GENE EXPRESSION SYSTEM; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOGENICITY; INTESTINE LYMPHATIC TISSUE; ORAL DRUG ADMINISTRATION; PAIN; PARENTERAL DRUG ADMINISTRATION; PROTEIN TARGETING; REVIEW; TRANSGENIC PLANT; VACCINE PRODUCTION;

ADMINISTRATION, ORAL; ANIMALS; CHLAMYDOMONAS REINHARDTII; GENE EXPRESSION; HUMANS; IMMUNITY, MUCOSAL; LEGISLATION, DRUG; MICE; PLANT COMPONENTS; PLANTS, GENETICALLY MODIFIED; TISSUE CULTURE TECHNIQUES; TOBACCO; VACCINES, EDIBLE; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 20444369915     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01336.x     Document Type: Review

References (71)

1. Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK, Arntzen CJ. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl Acad. Sci. USA 1996; 93: 5335-40.
2. Brennan FR, Jones TD, Gilleland LB et al. Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus. Microbiology 1999; 145: 211-20.
3. Rigano MM, Alvarez ML, Pinkhasov J et al. Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana. Plant Cell Rep. 2003; 22: 502-508.
4. Mason HS, Haq TA, Clements JD, Arntzen CJ. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 1998; 16: 1336-43.
5. Mason HS, Lam DM, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl Acad. Sci. USA 1992; 89: 11 745-9.
6. Fitchen J, Beachy RN, Hein MB. Plant virus expressing hybrid coat protein with added murine epitope elicits autoantibody response. Vaccine 1995; 13: 1051-7.
7. Walmsley AM, Alvarez ML, Jin Y et al. Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato. Plant Cell Rep. 2003; 21: 1020-26.
8. Walmsley AM, Arntzen CJ. Plant cell factories and mucosal vaccines. Curr. Opin. Biotechnol. 2003; 14: 145-50.
9. Cripps AW, Kyd JM, Foxwell AR. Vaccines and mucosal immunisation. Vaccine 2001; 19: 2513-5.
10. Dietrich G, Griot-Wenk M, Metcalfe IC, Lang AB, Viret JF. Experience with registered mucosal vaccines. Vaccine 2003; 21: 678-83.
11. Lerouge P, Cabanes-Macheteau M, Rayon C, Fischette-Laine AC, Gomord V, Faye L. N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol. Biol. 1998; 38: 31-48.
12. Van Eck J, Walmsley AM, Daniell D. Tomato transformation - the nuclear and chloroplast genomes. In: Curtiss IS (ed.) Transgenic Crops of the World. Dordrecht, the Netherlands: Kluwer Academic Publishers, 2004; 405-23.
13. Goldschmidt-Clermont M. Transgenic expression of aminoglycoside adenine transferase in the chloroplast: a selectable marker of site-directed transformation of chlamydomonas. Nucl. Acids Res. 1991; 19: 4083-9.
14. Svab Z, Maliga P. High-frequency plastid transformation in tobacco by selection for a chimeric aadA gene. Proc. Natl Acad. Sci. USA 1993; 90: 913-7.
15. Raven PH, Evert RF, Eichhorn SE. Biology of Plants, 4th edn. New York: Worth Publishers, 1986.
16. Franklin SE, Mayfield SP. Prospects for molecular farming in the green alga Chlamydomonas. Curr. Opin. Plant Biol. 2004; 7: 159-65.
17. Fuhrmann M, Oertel W, Hegemann P. A synthetic gene coding for the green fluorescent protein (GFP) is a versatile reporter in Chlamydomonas reinhardtii. Plant J. 1999; 19: 353-61.
18. Lumbreras VDRS, Purton S. Efficient foreign gene expression in Chlamydomonas reinhardtii mediated by an endogenous intron. Plant J. 1998; 14: 441-7.
19. Kovar JL, Zhang J, Funke RP, Weeks DP. Molecular analysis of the acetolactate synthase gene of Chlamydomonas reinhardtii and development of a genetically engineered gene as a dominant selectable marker for genetic transformation. Plant J. 2002; 29: 109-17.
20. Franklin SE, Ngo B, Efuet E, Mayfield SP. Development of a GFP reporter gene for Chlamydomonas reinhardtii chloroplast. Plant J. 2002; 30: 733-44.
21. Mayfield SP, Franklin SE, Lerner RA. Expression and assembly of a fully active antibody in algae. Proc. Natl Acad. Sci. USA 2003; 100: 438-42.
22. Tepfer M, Casse-Delbart F. Agrobacterium rhizogenes as a vector for transforming higher plants. Microbiol. Sci. 1987; 4: 24-8.
23. Rao SR, Ravishankar GA. Plant cell cultures: Chemical factories of secondary metabolites. Biotechnol. Adv. 2002; 20: 101-53.
24. Gaume A, Komarnytsky S, Borisjuk N, Raskin I. Rhizosecretion of recombinant proteins from plant hairy roots. Plant Cell Rep. 2003; 21: 1188-93.
25. Medina-Bolivar F, Wright R, Funk V et al. A non-toxic lectin for antigen delivery of plant-based mucosal vaccines. Vaccine 2003; 21: 997-1005.
26. Li W, Asada Y, Yoshikawa T. Antimicrobial flavonoids from Glycyrrhiza glabra hairy root cultures. Planta Med. 1998; 64: 746-7.
27. Kunshi M, Shimomura K, Takida M, Kitanaka S. Growth and ginsenoside production of adventitious and hairy root cultures in an interspecific hybrid ginseng (Panax ginseng x P. quinquefolium). Nat. Med. 1998; 52: 1-4.
28. Sevon N, Hiltunen R, Caldentey KMO. Somoclonal variation in transformed roots and protoplast-derived hairy root cultures of Hyoscyamus muticus. Planta Med. 1998; 64: 37-41.
29. Shi HP, Kintzios S. Genetic transformation of Pueraria phaseoloides with Agrobacterium rhizogenes and puerarin production in hairy roots. Plant Cell Rep. 2003; 21: 1103-107.
30. Hughes EH, Hong SB, Gibson SI, Shanks JV, San KY. Expression of a feedback-resistant anthranilate synthase in Catharanthus roseus hairy roots provides evidence for tight regulation of terpenoid indole alkaloid levels. Biotechnol. Bioeng. 2004; 86: 718-27.
31. Zhang L, Ding R, Chai Y et al. Engineering tropane biosynthetic pathway in Hyoscyamus niger hairy root cultures. Proc. Natl Acad. Sci. USA 2004; 101: 6786-91.
32. Sharp JM, Doran PM. Characterization of monoclonal antibody fragments produced by plant cells. Biotechnol. Bioeng. 2001; 73: 338-46.
33. Elson CO, Ealding W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 1984; 133: 2892-7.
34. Clements JD, Hartzog NM, Lyon FL. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 1988; 6: 269-77.
35. Millar DG, Hirst TR, Snider DP. Escherichia coli heat labile enterotoxin B sununit is a more potent mucosal adjuvant than its closely related homologue, the B sununit of cholera toxin. Infect. Immun. 2001; 69: 3476-82.
36. Martin M, Metzger DJ, Michalek SM, Connell TD, Russell MW. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb. Infect. Immun. 2000; 68: 281-7.
37. Plant A, Williams R, Jackson ME, Williams NA. The B subunit of Escherichia coli heat labile enterotoxin abrogates oral tolerance, promoting predominantly Th2-type immune responses. Eur. J. Immunol. 2003; 33: 3186-95.
38. Richards CM, Aman AT, Hirst TR, Hill TJ, Williams NA. Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant. J. Virol. 2001; 75: 1664-71.
39. Haq TA, Mason HS, Clements JD, Arntzen CJ. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 1995; 268: 714-6.
40. Chikwamba RK, Cunnick J, Hathaway D et al. A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res. 2002; 11: 479-93.
41. Walmsley AM, Kirk DD, Mason HS. Passive immunization of mice pups through oral immunization of dams with a plant-derived vaccine. Immunol. Lett. 2003; 86: 71-6.
42. Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM, Arntzen CJ. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nature Med. 1998; 4: 607-609.
43. Fan E, Merritt EA, Zhang Z et al. Exploration of the GM1 receptor-binding site of heat-labile enterotoxin and cholera toxin by phenyl-ring-containing galactose derivatives. Acta Crystallog. Biolog. Crystallog. 2001; 57: 201-212.
44. Sixma TK, Pronk SE, Kalk KH et al. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 1991; 351: 371-7.
45. Kim TG, Gruber A, Langridge WH. HIV-1 gp120, V3 cholera toxin B subunit fusion gene expression in transgenic potato. Protein Expr. Purif. 2004; 37: 196-202.
46. Schodel F, Enders G, Jung MC, Will H. Recognition of a hepatitis B virus nucleocapsid T-cell epitope expressed as a fusion protein with the subunit B of Escherichia coli heat labile enterotoxin in attenuated salmonellae. Vaccine 1990; 8: 569-72.
47. Lipscombe M, Charles IG, Roberts M, Dougan G, Tite J, Fairweather NF. Intranasal immunization using the B subunit of the Escherichia coli heat-labile toxin fused to an epitope of the Bordetella pertussis P.69 antigen. Mol. Microbiol. 1991; 5: 1385-92.
48. Gonzalez RA, Sanchez J, Holmgren J, Lopez S, Arias CF. Immunological characterization of a rotavirus-neutralizing epitope fused to the cholera toxin B subunit. Gene 1993; 133: 227-32.
49. Dertzbaugh MT, Elson CO. Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition. Infect. Immun. 1993; 61: 384-90.
50. Dertzbaugh MT, Elson CO. Comparative effectivenes of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines. Infect. Immun. 1993; 61: 48-55.
51. Backstrom M, Lebens M, Schodel F, Holmgren J. Insertion of a HIV-1-neutralizing epitope in a surface-exposed internal region of the cholera toxin B-subunit. Gene 1994; 149: 211-17.
52. Backstrom M, Holmgren J, Schodel F, Lebens M. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Esherichia coli. Gene 1995; 165: 163-71.
53. Zhang T, Li E, Stanley SLJ. Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response. Infect. Immun. 1995; 63: 1349-55.
54. Liljeqvist S, Stahl S, Andreoni C, Binz H, Uhlen M, Murby M. Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding. J. Immunol. Meth. 1997; 210: 125-35.
55. Bagdasarian MM, Nagai M, Frey J, Bagdasarian M. Immunogenicity of Actinobacillus ApxIA toxin eptiopes fused to the E. coli heat-labile enterotoxin B subunit. Vaccine 1999; 17: 441-7.
56. O'Dowd AM, Bolting CH, Precious B, Shawcross R, Randall RE. Novel modifications to the C-terminus of LTB that facilitate site-directed chemical coupling of antigens and the development of LTB as a carrier for mucosal vaccines. Vaccine 1999; 17: 1442-53.
57. Arakawa T, Yu J, Chong DK, Hough J, Engen PC, Langridge WH. A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat. Biotechnol. 1998; 16: 934-8.
58. Yu J, Langridge WH. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. Biotechnol. 2001; 19: 548-52.
59. Lee JY, Yu J, Henderson D, Langridge WH. Plant-synthesized E. coli CFA/I fimbrial protein protects Caco-2 cells from bacterial attachment. Vaccine 2004; 23: 222-31.
60. Castañón S, Martin-Alonso JM, Marin MS et al. The effect of the promoter on expression of VP60 gene from rabbit hemorrhagic disease virus in potato plants. Plant Sci. 2002; 162: 87-95.
61. Hood EE, Woodard SL, Horn ME. Monoclonal antibody manufacturing in transgenic plants - myths and realities. Curr. Opin. Biotechnol. 2002; 13: 630-35.
62. Goldstein DA, Thomas JA. Biopharmaceuticals derived from genetically modified plants. Q. J. Med. 2004; 97: 705-716.
63. Tackaberry ES, Prior F, Bell M et al. Increased yield of heterologous viral glycoprotein in the seeds of homozygous transgenic tobacco plants cultivated underground. Genome 2003; 46: 521-6.
64. Daniell H, Lee SB, Panchal T, Wiebe PO. Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J. Mol. Biol. 2001; 311: 1001-1009.
65. Tregoning JS, Nixon P, Kuroda H et al. Expression of tetanus toxin Fragment C in tobacco chloroplasts. Nucl. Acids Res. 2003; 31: 1174-9.
66. Joensuu JJ, Kotiaho M, Riipi T et al. Fimbrial subunit protein FaeG expressed in transgenic tobacco inhibits the binding of F4ac enterotoxigenic Escherichia coli to porcine enterocytes. Transgenic Res. 2004; 13: 295-8.
67. Biemelt S, Sonnewald U, Galmbacher P, Willmitzer L, Muller M. Production of human papillomavirus type 16 virus-like particles in transgenic plants. J. Virol. 2003; 77: 9211-20.
68. Zuo XF, Zhang XY, Shan L, Xiao CY, He DX, Ru BG. Expression of human intestinal trefoil factor (hITF) gene in lettuce. Acta Botanica Sinica 2001; 43: 1047-51.
69. Kapusta J, Modelska A, Figlerowicz M et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J. 1999; 13: 1796-9.
70. Yusibov V, Hooper DC, Spitsin SV et al. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 2002; 20: 3155-64.
71. Flinn JE. Plants as Biofactories, 1st edn. Naperville, IL: Bio-Endeavors International, 2004.